Myeloma Paper of the Day, July 15th, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Interleukin-6 is a prognostic biomarker for POEMS syndrome associated with EFS and OS (patients with elevated IL-6 had 17-fold increased risk of death vs. those with normal values), along with hypoalbuminemia and a high Wang score.”
Title: Interleukin-6 is a highly prognostic biomarker for POEMS syndrome
Authors: Joselle Cook, Rahma Warsame, Maryam Omar, Francis K. Buadi, Nadine Abdallah, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Moritz Binder, Eli Muchtar, Amie Fonder, Yi L. Hwa, Miriam A. Hobbs, Yi Lin, Wilson I. Gonsalves, Morie A. Gertz, Shaji K. Kumar, S. Vincent Rajkumar, Angela Dispenzieri
You can read the Full Article in Leukemia.
You can find more posts featuring Robert Orlowski in OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023